Acquired Acute Myelogenous Leukemia after Therapy for Acute Promyelocytic Leukemia with t(15;17): a Case Report and Review of the Literature
PDF

How to Cite

Betancourt-García, R. D., Castro, J., Fernández, A. C., López-Enríquez, A., Fradera, J., & Pacheco, E. (2009). Acquired Acute Myelogenous Leukemia after Therapy for Acute Promyelocytic Leukemia with t(15;17): a Case Report and Review of the Literature. Puerto Rico Health Sciences Journal, 28(2). Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/205

Abstract

Therapy-related myelodysplastic syndrome (t-MDS) and therapy-related acute myelogenous leukemia (t-AML) in patients with acute promyelocytic leukemia (APL) are rare events. The cumulative exposure to chemotherapy with alkylating agents and topoisomerase II inhibitors is associated with t-AML that may develop any time after the completion of the treatment. We report the case of an acquired AML who previously received therapy for APL, after two years of being diagnosed. The diagnosis was established by morphologic findings, membrane markers, cytogenetic studies, and fluorescence in situ hybridization (FISH). To our knowledge this is the first documented case in Puerto Rico of a patient with APL that developed a t-AML without the characteristic chromosomal and morphologic findings of APL.
PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).